LEADER 04343nam 2200697 450 001 9910797575603321 005 20230801234717.0 010 $a1-62637-336-1 024 7 $a10.1515/9781626373365 035 $a(CKB)3710000000466065 035 $a(EBL)4352968 035 $a(SSID)ssj0001544234 035 $a(PQKBManifestationID)16135041 035 $a(PQKBTitleCode)TC0001544234 035 $a(PQKBWorkID)14334109 035 $a(PQKB)11328152 035 $a(MiAaPQ)EBC4352968 035 $a(Au-PeEL)EBL4352968 035 $a(CaPaEBR)ebr11150312 035 $a(OCoLC)936881035 035 $a(DE-B1597)623582 035 $a(DE-B1597)9781626373365 035 $a(EXLCZ)993710000000466065 100 $a20160209h20122012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aDriving down the cost of drugs $ebattling big pharma in the statehouse /$fRamo?n Castellblanch 210 1$aBoulder, Colorado ;$aLondon, [England] :$cFirstForumPress,$d2012. 210 4$d©2012 215 $a1 online resource (186 p.) 300 $aDescription based upon print version of record. 311 $a1-935049-45-3 320 $aIncludes bibliographical references and index. 327 $aTitle page; copyright page; Dedication; Contents; Preface; Acknowledgments; ch1-David, Goliath, and Prescription Drugs; ch2-How Drugs Got So Expensive; Getting Patent Privileges; Making the FDA a Partner and the Rise of the Blockbusters; Fighting Government Oversight and Exploiting the Blockbusters; The Blockbusters' Toll on America; ch3-Vermont Raises the Cry; The Road to S 300; 1999; S 300; Epilogue; ch4-As Goes Maine; Maine Background; Low-cost Drugs for the Elderly; Senate Leadership Commitments to Supporting Price Controls; Leinonen; Northeast Legislators; LD 2599; Industry Response 327 $aPublic Support to the RescueKing-Pingree Negotiations; Maine Rx; PhRMA v. Concannon; Maine Rx Plus; Postscript; ch5-PhRMA Tries Stopping State Action; PhRMA Political Spending in the Early 2000s; Post-Maine Rx State and Local Legislation; PhRMA's Turn to Congress; Industry Building Its Economic Power; Advocates' Continued Fighting after Part D; ch6-So Goes California; California Overview; 1999-2003; 2004: Legislative Leadership Taking the Stage; The Rise of Tension between the Governor and Legislative Leadership; 2005; 2006; Making a Deal; Implementation Delayed 327 $ach7-Politically Organizing for Access to MedicinesHearing Voters' Righteous Indignation; Allying with Powerful Progressive Organizations; Politically Isolating the Pharmaceutical Industry; "Framing" after Righteous Indignation; Inferences beyond Fighting for Medicines; Implications for US Health Policy; Appendix: Useful Websites on Health Care Policy and Politics; Bibliography; Index; About the Book 330 $aHow can health-access advocates beat the wealthy pharmaceutical industry, which has the biggest spending lobby in Washington? Ramón Castellblanch provides a ringside seat at the battle as he reveals how activists in Vermont, Maine, and California took on Big Pharma in their state legislatures to promote better and cheaper access to prescription drugs?and ultimately pushed Congress to enact a Medicare prescription drug benefit. He also draws lessons from these cases about the possibilities for success elsewhere in the health policy arena, highlighting the crucial role that voters' righteous indignation plays in fueling popular support for grassroots political leaders who are taking on powerful business interests. 606 $aPrescription pricing$zCalifornia 606 $aPrescription pricing$zMaine 606 $aPrescription pricing$zVermont 606 $aDrugs$xPrices$zCalifornia 606 $aDrugs$xPrices$zMaine 606 $aDrugs$xPrices$zVermont 615 0$aPrescription pricing 615 0$aPrescription pricing 615 0$aPrescription pricing 615 0$aDrugs$xPrices 615 0$aDrugs$xPrices 615 0$aDrugs$xPrices 676 $a368.38/24 700 $aCastellblanch$b Ramo?n$f1948-$01543352 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910797575603321 996 $aDriving down the cost of drugs$93796752 997 $aUNINA